Get the Stockscreener App
48.73
1.42%
0.68
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $48.73, with a volume of 632.31K.
It is up +1.42% in the last 24 hours and up +25.69% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
See More
Previous Close:
$48.05
Open:
$48.16
24h Volume:
632.31K
Relative Volume:
0.54
Market Cap:
$2.62B
Revenue:
$238.11M
Net Income/Loss:
$-31.45M
P/E Ratio:
-76.93
EPS:
-0.6334
Net Cash Flow:
$7.66M
1W Performance:
+4.95%
1M Performance:
+25.69%
6M Performance:
+46.64%
1Y Performance:
+227.05%
1-Day Range:
$47.29
$48.80
1-Week Range:
$45.95
$49.93
52-Week Range:
$13.64
$49.93
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
48.73 | 2.67B | 238.11M | -31.45M | 7.66M | -0.6334 |
ABT
Abbott Laboratories
|
111.25 | 191.92B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
339.21 | 133.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
91.27 | 116.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.83 | 74.52B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
91.60 | 53.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Wells Fargo | Overweight |
| Dec-01-25 | Initiated | Mizuho | Outperform |
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
First Light Asset Management (AXGN) discloses 7.58% Axogen stake for Mathew Arens - Stock Titan
Axogen (AXGN) Q2 2026 Earnings Call Transcript - AOL.com
Axogen EVP Marc Began Executes Stock Option Exercise and Sells Shares Under 10b5-1 Plan - Kalkine Media
Axogen Director Amy McBride-Wendell Executes and Sells 13,353 Shares Under 10b5-1 Plan - Kalkine Media
AxoGen (NASDAQ:AXGN) EVP Marc Began Sells 67,500 Shares of Stock - MarketBeat
AxoGen (NASDAQ:AXGN) Director Sells $646,552.26 in Stock - MarketBeat
Axogen Insider Sold Shares Worth $646,592, According to a Recent SEC Filing - marketscreener.com
Axogen Insider Sold Shares Worth $3,195,788, According to a Recent SEC Filing - marketscreener.com
Q4 2025 AxoGen Inc Earnings Call Transcript - GuruFocus
AxoGen, Inc. $AXGN Shares Sold by Wasatch Advisors LP - MarketBeat
Kathy Johnson Weiler Sells 14,150 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Axogen, Inc. SEC Filing (Aug 11, 2026) - Stock Titan
Axogen (AXGN) Is Up 5.4% After Raising 2026 Revenue Outlook Despite Ongoing Losses – Has The Bull Case Changed? - simplywall.st
Axogen Raises Its Revenue Outlook to at Least $279 Million But Does It Deserve An Upgrade? - Smartkarma
Axogen stock hits 52-week high at 47.09 USD By Investing.com - Investing.com UK
AxoGen (NASDAQ:AXGN) Reaches New 52-Week HighTime to Buy? - MarketBeat
Axogen stock hits 52-week high at 47.09 USD - Investing.com
Axogen, Inc. (AXGN) options chain - Yahoo Finance Australia
Assenagon Asset Management S.A. Trims Stock Position in AxoGen, Inc. $AXGN - MarketBeat
MFG Wealth Management Inc. Takes $1.20 Million Position in AxoGen, Inc. $AXGN - MarketBeat
AxoGen Inc (AXGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Axogen, Inc. (AXGN) director completes 14,150-share stock sale under Rule 10b5-1 plan - Stock Titan
AxoGen Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
HC Wainwright Predicts AxoGen's Q1 Earnings (NASDAQ:AXGN) - MarketBeat
Axogen: The Regulatory Moat Is Becoming A Commercial Flywheel (NASDAQ:AXGN) - Seeking Alpha
Axogen Inc (NASDAQ: AXGN) Share Price, AXGN Stock News, AXGN Share Price & Updates - Kalkine
Arrowstreet Capital Limited Partnership Lowers Stock Holdings in AxoGen, Inc. $AXGN - MarketBeat
Analysts Have Made A Financial Statement On Axogen, Inc.'s (NASDAQ:AXGN) Second-Quarter Report - Sahm
Trace Biosciences Raises Strategic Investment From Axogen - Pulse 2.0
Vanguard Capital Management (AXGN) discloses 4.99% Axogen Inc ownership on Schedule 13G/A - Stock Titan
A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $53 to $55 - Moomoo
Citizens raises AxoGen stock price target to $55 on strong growth - Investing.com UK
Healthcare of Ontario Pension Plan Trust Fund Makes New Investment in AxoGen, Inc. $AXGN - MarketBeat
Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and Incyte (INCY) - The Globe and Mail
AxoGen (NASDAQ:AXGN) Given New $55.00 Price Target at Canaccord Genuity Group - MarketBeat
AxoGen Inc (AXGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - tradingkey.com
Axogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
AXGN Looks 168.4% Overvalued on GF Value™ - GuruFocus
Axogen invests in Trace Biosciences’ nerve imaging technology By Investing.com - Investing.com Nigeria
AxoGen: Q2 Earnings Snapshot - marketscreener.com
Axogen, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
Axogen Q2 Revenue Rises 23 Percent to $69.7 Million - quiverquant.com
Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology – Company AnnouncementFT.com - Financial Times
BRIEF-AxoGen Q2 Revenue USD 69.7 Million Vs. IBES Estimate USD 67.1 Million - TradingView
Press Release: Axogen, Inc. Reports Second Quarter 2026 Financial Results - moomoo.com
Earnings Flash (AXGN) Axogen Reports Q2 Revenue $69.7M, vs. FactSet Est of $67.1M - marketscreener.com
How Axogen Inc. (AXGN) Affects Rotational Strategy Timing - Stock Traders Daily
Axogen earnings on deck as nerve repair reimbursement gains gather steam - Investing.com UK
AxoGen Inc (AXGN) Institutional Confidence - TradingKey
AxoGen Inc (AXGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AxoGen Inc (AXGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):